{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:10:52Z","timestamp":1793772652258,"version":"4.6.1"},"reference-count":130,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.trre.2021.100626","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T21:43:17Z","timestamp":1620078197000},"page":"100626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The potential of biomarkers of fibrosis in chronic lung allograft dysfunction"],"prefix":"10.1016","volume":"35","author":[{"given":"Eline A.","family":"van der Ploeg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbro N.","family":"Melgert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janette K.","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Tji","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2021.100626_bb0005","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.healun.2015.08.003","article-title":"The registry of the International Society for Heart and Lung Transplantation: thirty-second official adult heart transplantation report - 2015; focus theme: early graft failure","volume":"34","author":"Lund","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2021.100626_bb0010","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/MOT.0000000000000753","article-title":"Survival in adult lung transplantation: where are we in 2020?","volume":"25","author":"Bos","year":"2020","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.trre.2021.100626_bb0015","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1164\/ajrccm.161.6.9909092","article-title":"Bronchiolitis obliterans syndrome after lung transplantation and health-related quality of life","volume":"161","author":"van Den Berg","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trre.2021.100626_bb0020","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/14017431.2020.1726444","article-title":"Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience","volume":"54","author":"Nyk\u00e4nen","year":"2020","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.trre.2021.100626_bb0025","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.healun.2018.09.020","article-title":"Validation of a post-transplant chronic lung allograft dysfunction classification system","volume":"38","author":"Van Herck","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2021.100626_bb0030","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.15864","article-title":"When tissue is the issue: a histological review of chronic lung allograft dysfunction","author":"Verleden","year":"2020","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"key":"10.1016\/j.trre.2021.100626_bb0035","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1183\/09031936.00107514","article-title":"An international ISHLT\/ATS\/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome","volume":"44","author":"Meyer","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.trre.2021.100626_bb0040","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0046-8177(85)80130-1","article-title":"Pathologic pulmonary alterations in long-term human heart-lung transplantation","volume":"16","author":"Yousem","year":"1985","journal-title":"Hum Pathol"},{"key":"10.1016\/j.trre.2021.100626_bb0045","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment-a consensus report from the pulmonary council of the ISHLT","volume":"38","author":"Verleden","year":"2019","journal-title":"J Hear Lung Transplant Off Publ Int Soc Hear Transplant"},{"key":"10.1016\/j.trre.2021.100626_bb0050","doi-asserted-by":"crossref","unstructured":"Bennett D, Lanzarone N, Fossi A, Perillo F, De Vita E, Luzzi L, et al. Pirfenidone in chronic lung allograft dysfunction: a single cohort study. Panminerva Med 2020;62:143\u20139. doi:10.23736\/S0031-0808.19.03840-0.","DOI":"10.23736\/S0031-0808.19.03840-0"},{"key":"10.1016\/j.trre.2021.100626_bb0055","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.healun.2011.01.712","article-title":"Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction","volume":"30","author":"Sato","year":"2011","journal-title":"J Hear Lung Transplant Off Publ Int Soc Hear Transplant"},{"key":"10.1016\/j.trre.2021.100626_bb0060","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/TP.0b013e31822bf790","article-title":"Survival determinants in lung transplant patients with chronic allograft dysfunction","volume":"92","author":"Verleden","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100626_bb0065","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.healun.2019.03.008","article-title":"Chronic lung allograft dysfunction: definition and update of restrictive allograft syndrome-a consensus report from the pulmonary council of the ISHLT","volume":"38","author":"Glanville","year":"2019","journal-title":"J Hear Lung Transplant Off Publ Int Soc Hear Transplant"},{"key":"10.1016\/j.trre.2021.100626_bb0070","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.21037\/jtd.2017.07.81","article-title":"Chronic lung allograft dysfunction phenotypes and treatment","volume":"9","author":"Verleden","year":"2017","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.trre.2021.100626_bb0075","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1007\/s00330-016-4643-5","article-title":"Restrictive allograft syndrome after lung transplantation: new radiological insights","volume":"27","author":"Dubbeldam","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.trre.2021.100626_bb0080","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.healun.2018.09.020","article-title":"Validation of a post-transplant chronic lung allograft dysfunction classification system","volume":"38","author":"Van Herck","year":"2019","journal-title":"J Hear Lung Transplant Off Publ Int Soc Hear Transplant"},{"key":"10.1016\/j.trre.2021.100626_bb0085","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1513\/AnnalsATS.201410-476MG","article-title":"Characteristic patterns in the fibrotic lung: comparing idiopathic pulmonary fibrosis with chronic lung allograft dysfunction","volume":"12","author":"Fernandez","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.trre.2021.100626_bb0090","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.healun.2019.02.001","article-title":"The pleural mesothelium and transforming growth factor-\u03b2(1) pathways in restrictive allograft syndrome: a pre-clinical investigation","volume":"38","author":"Sacreas","year":"2019","journal-title":"J Hear Lung Transplant Off Publ Int Soc Hear Transplant"},{"key":"10.1016\/j.trre.2021.100626_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219526","article-title":"Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART","volume":"14","author":"Dold","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.trre.2021.100626_bb0100","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12931-019-1118-7","article-title":"Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort","volume":"20","author":"Organ","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.trre.2021.100626_bb0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jtcvs.2014.02.059","article-title":"Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients","volume":"148","author":"Jaksch","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.trre.2021.100626_bb0110","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/1756-185X.13804","article-title":"Correlation between serological biomarkers of extracellular matrix turnover and lung fibrosis and pulmonary artery hypertension in patients with systemic sclerosis","volume":"23","author":"Kubo","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.trre.2021.100626_bb0115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-5223(97)70144-2","article-title":"Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation","volume":"114","author":"Kroshus","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.trre.2021.100626_bb0120","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/cid\/ciy1047","article-title":"Community-acquired respiratory viruses are a risk factor for chronic lung allograft dysfunction","volume":"69","author":"Peghin","year":"2019","journal-title":"Clin Infect Dis an Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.trre.2021.100626_bb0125","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2165\/00003495-200565060-00004","article-title":"Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies","volume":"65","author":"Scott","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.trre.2021.100626_bb0130","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1164\/ajrccm.155.6.9196117","article-title":"Scar collagen deposition in the airways of allografts of lung transplant recipients","volume":"155","author":"Zheng","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trre.2021.100626_bb0135","series-title":"NIH Public Access","first-page":"470","volume":"92","author":"Lapar","year":"2012"},{"key":"10.1016\/j.trre.2021.100626_bb0140","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1600-6143.2009.02558.x","article-title":"Posttransplant bronchiolitis obliterans syndrome is associated with bronchial epithelial to mesenchymal transition","volume":"9","author":"Hodge","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2021.100626_bb0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1183\/09031936.00141010","article-title":"Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis","volume":"39","author":"Mubarak","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.trre.2021.100626_bb0150","first-page":"L115","article-title":"Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-beta1 in vitro","volume":"297","author":"Nasreen","year":"2009","journal-title":"Am J Phys Lung Cell Mol Phys"},{"key":"10.1016\/j.trre.2021.100626_bb0155","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.humimm.2019.03.012","article-title":"The role of donor-derived exosomes in lung allograft rejection","volume":"80","author":"Ravichandran","year":"2019","journal-title":"Hum Immunol"},{"key":"10.1016\/j.trre.2021.100626_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2020.07.001","article-title":"Circulating exosomes with lung self-antigens as a biomarker for chronic lung allograft dysfunction: a retrospective analysis","author":"Sharma","year":"2020","journal-title":"J Hear Lung Transplant Off Publ Int Soc Hear Transplant"},{"key":"10.1016\/j.trre.2021.100626_bb0165","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMra1300575","article-title":"Fibrosis--a common pathway to organ injury and failure","volume":"372","author":"Rockey","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2021.100626_bb0170","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1378\/chest.13-2688","article-title":"Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosis","volume":"146","author":"Jaffar","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.trre.2021.100626_bb0175","article-title":"Osteoprotegerin is elevated in pulmonary fibrosis and associates with IPF progression","volume":"2020","author":"Habibie","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.trre.2021.100626_bb0180","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nri1418","article-title":"Matrix metalloproteinases as modulators of inflammation and innate immunity","volume":"4","author":"Parks","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trre.2021.100626_bb0185","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nri2852","article-title":"The impact of the extracellular matrix on inflammation","volume":"10","author":"Sorokin","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trre.2021.100626_bb0190","first-page":"1355","article-title":"Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis","volume":"34","author":"Merdad","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.trre.2021.100626_bb0195","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pharmthera.2013.03.009","article-title":"Matrix metalloproteinase (MMP)-9: a proximal biomarker for cardiac remodeling and a distal biomarker for inflammation","volume":"139","author":"Halade","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.trre.2021.100626_bb0200","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00074-2016","article-title":"MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis","volume":"3","author":"Bauer","year":"2017","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.trre.2021.100626_bb0205","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.healun.2011.06.007","article-title":"The airway epithelium is a direct source of matrix degrading enzymes in bronchiolitis obliterans syndrome","volume":"30","author":"Banerjee","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2021.100626_bb0210","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1600-6143.2005.00751.x","article-title":"Inhibition of obliterative airway disease development in murine tracheal allografts by matrix metalloproteinase-9 deficiency","volume":"5","author":"Fernandez","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2021.100626_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21113878","article-title":"A tale of two Proteolytic machines: matrix Metalloproteinases and the ubiquitin-proteasome system in pulmonary fibrosis","volume":"21","author":"Roque","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trre.2021.100626_bb0220","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.ajpath.2011.05.032","article-title":"Regression of allograft airway fibrosis: the role of MMP-dependent tissue remodeling in obliterative bronchiolitis after lung transplantation","volume":"179","author":"Sato","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trre.2021.100626_bb0225","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S1053-2498(01)00325-4","article-title":"Sputum levels of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, and their ratio correlate with airway obstruction in lung transplant recipients: relation to tumor necrosis factor-alpha and interleukin-10","volume":"20","author":"Beeh","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2021.100626_bb0230","doi-asserted-by":"crossref","first-page":"104591","DOI":"10.1016\/j.phrs.2019.104591","article-title":"Matrix metalloproteinase: an upcoming therapeutic approach for idiopathic pulmonary fibrosis","volume":"152","author":"Mahalanobish","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.trre.2021.100626_bb0235","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1183\/09031936.05.00091804","article-title":"Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation","volume":"25","author":"Hubner","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.trre.2021.100626_bb0240","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1067\/mai.2000.105316","article-title":"Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in acute asthma","volume":"105","author":"Tanaka","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trre.2021.100626_bb0245","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/ajt.14166","article-title":"T cells promote bronchial epithelial cell secretion of matrix Metalloproteinase-9 via a C-C chemokine receptor type 2 pathway: implications for chronic lung allograft dysfunction","volume":"17","author":"Pain","year":"2017","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"key":"10.1016\/j.trre.2021.100626_bb0250","first-page":"28","article-title":"YKL-40 and matrix metalloproteinases as potential biomarkers of inflammation and fibrosis in the development of bronchiolitis obliterans syndrome","volume":"30","author":"Kastelijn","year":"2013","journal-title":"Sarcoidosis Vasc Diffus Lung Dis Off J WASOG"},{"key":"10.1016\/j.trre.2021.100626_bb0255","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0168-8278(00)80095-1","article-title":"Serum YKL-40 is increased in patients with hepatic fibrosis","volume":"32","author":"Johansen","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.trre.2021.100626_bb0260","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1042\/bj20020075","article-title":"The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways","volume":"365","author":"Recklies","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.trre.2021.100626_bb0265","doi-asserted-by":"crossref","first-page":"21082","DOI":"10.1074\/jbc.M601153200","article-title":"The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation","volume":"281","author":"Bigg","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trre.2021.100626_bb0270","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1056\/NEJMoa073600","article-title":"A chitinase-like protein in the lung and circulation of patients with severe asthma","volume":"357","author":"Chupp","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2021.100626_bb0275","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00408-014-9647-9","article-title":"Evaluation of circulating YKL-40 levels in idiopathic interstitial pneumonias","volume":"192","author":"Korthagen","year":"2014","journal-title":"Lung"},{"key":"10.1016\/j.trre.2021.100626_bb0280","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.rmed.2010.02.026","article-title":"Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis","volume":"104","author":"Furuhashi","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.trre.2021.100626_bb0285","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.rmed.2010.09.012","article-title":"Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis","volume":"105","author":"Korthagen","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.trre.2021.100626_bb0290","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1056\/NEJMoa0708801","article-title":"Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function","volume":"358","author":"Ober","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2021.100626_bb0295","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.rmed.2006.12.006","article-title":"A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker","volume":"101","author":"Kruit","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.trre.2021.100626_bb0300","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1165\/ajrcmb.17.4.2253","article-title":"KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts","volume":"17","author":"Hirasawa","year":"1997","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.trre.2021.100626_bb0305","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/ajrccm.159.2.9806064","article-title":"Lung epithelium-specific proteins: characteristics and potential applications as markers","volume":"159","author":"Hermans","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trre.2021.100626_bb0310","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1378\/chest.127.1.403","article-title":"Serum KL-6 and surfactant proteins a and D in pediatric interstitial lung disease","volume":"127","author":"Al-Salmi","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.trre.2021.100626_bb0315","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.21037\/jtd.2018.07.76","article-title":"Sequential changes of serum KL-6 predict the progression of interstitial lung disease","volume":"10","author":"Jiang","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.trre.2021.100626_bb0320","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.3899\/jrheum.160339","article-title":"Elevated serum Krebs von den Lungen-6 in early disease predicts subsequent deterioration of pulmonary function in patients with systemic sclerosis and interstitial lung disease","volume":"43","author":"Kuwana","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.trre.2021.100626_bb0325","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2019.05.014","article-title":"Review: serum biomarkers in idiopathic pulmonary fibrosis and systemic sclerosis associated interstitial lung disease - frontiers and horizons","volume":"202","author":"Jee","year":"2019","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.trre.2021.100626_bb0330","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1399-3046.2010.01373.x","article-title":"Serum KL-6 level and the development of bronchiolitis obliterans syndrome in lung transplant recipients","volume":"14","author":"Haberman","year":"2010","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.trre.2021.100626_bb0335","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/01.tp.0000234952.46013.df","article-title":"Serum KL-6 as a marker for bronchiolitis obliterans syndrome after lung transplantation","volume":"82","author":"Walter","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100626_bb0340","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.trim.2018.10.006","article-title":"Changes in serum KL-6 levels are associated with the development of chronic lung allograft dysfunction in lung transplant recipients","volume":"52","author":"Bessa","year":"2019","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.trre.2021.100626_bb0345","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.healun.2011.07.010","article-title":"Comparison of serum KL-6 versus bronchoalveolar lavage neutrophilia for the diagnosis of bronchiolitis obliterans in lung transplantation","volume":"30","author":"Ohshimo","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2021.100626_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226488","article-title":"Use of serum KL-6 level for detecting patients with restrictive allograft syndrome after lung transplantation","volume":"15","author":"Berastegui","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.trre.2021.100626_bb0355","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12931-018-0798-8","article-title":"Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis","volume":"19","author":"Heukels","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.trre.2021.100626_bb0360","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jcf.2020.06.011","article-title":"Fibrocyte accumulation in the lungs of cystic fibrosis patients","volume":"19","author":"Kasam","year":"2020","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"key":"10.1016\/j.trre.2021.100626_bb0365","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0002-9440(10)62289-4","article-title":"CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury","volume":"166","author":"Moore","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trre.2021.100626_bb0370","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.biocel.2008.02.012","article-title":"Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis","volume":"40","author":"Andersson-Sj\u00f6land","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.trre.2021.100626_bb0375","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.biocel.2009.02.020","article-title":"Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis","volume":"41","author":"Mehrad","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.trre.2021.100626_bb0380","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.trre.2021.100626_bb0385","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.trre.2021.100626_bb0390","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1097\/TP.0000000000002589","article-title":"Regulation of endothelial-to-Mesenchymal transition by MicroRNAs in chronic allograft dysfunction","volume":"103","author":"Glover","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100626_bb0395","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/ajt.13185","article-title":"Dysregulated MicroRNA expression and chronic lung allograft rejection in recipients with antibodies to donor HLA","volume":"15","author":"Xu","year":"2015","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"key":"10.1016\/j.trre.2021.100626_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trim.2017.04.002","article-title":"Serum miRNAs as potential biomarkers for the bronchiolitis obliterans syndrome after lung transplantation","volume":"42","author":"Budding","year":"2017","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.trre.2021.100626_bb0405","doi-asserted-by":"crossref","first-page":"19309","DOI":"10.4238\/2015.December.29.40","article-title":"MicroRNA screening and functional study of obliterative bronchiolitis in a rat model simulating lung transplantation","volume":"14","author":"Wang","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.trre.2021.100626_bb0410","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1097\/TP.0000000000001595","article-title":"Role of circulating MicroRNAs in the Immunopathogenesis of rejection after pediatric lung transplantation","volume":"101","author":"Xu","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100626_bb0415","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.healun.2015.03.021","article-title":"MicroRNA-144 dysregulates the transforming growth factor-\u03b2 signaling cascade and contributes to the development of bronchiolitis obliterans syndrome after human lung transplantation","volume":"34","author":"Xu","year":"2015","journal-title":"J Hear Lung Transplant Off Publ Int Soc Hear Transplant"},{"key":"10.1016\/j.trre.2021.100626_bb0420","doi-asserted-by":"crossref","first-page":"31601","DOI":"10.1074\/jbc.M706078200","article-title":"Investigating the interaction between osteoprotegerin and receptor activator of NF-kappaB or tumor necrosis factor-related apoptosis-inducing ligand: evidence for a pivotal role for osteoprotegerin in regulating two distinct pathways","volume":"282","author":"Vitovski","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trre.2021.100626_bb0425","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3389\/fonc.2020.00462","article-title":"Osteoprotegerin: relationship to breast cancer risk and prognosis","volume":"10","author":"Geerts","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.trre.2021.100626_bb0430","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1111\/febs.14142","article-title":"Novel RANKL DE-loop mutants antagonize RANK-mediated osteoclastogenesis","volume":"284","author":"Wang","year":"2017","journal-title":"FEBS J"},{"key":"10.1016\/j.trre.2021.100626_bb0435","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pharmthera.2015.09.001","article-title":"Therapeutic applications of TRAIL receptor agonists in cancer and beyond","volume":"155","author":"Amarante-Mendes","year":"2015","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.trre.2021.100626_bb0440","first-page":"L664","article-title":"Gender influences the response to experimental silica-induced lung fibrosis in mice","volume":"299","author":"Brass","year":"2010","journal-title":"Am J Phys Lung Cell Mol Phys"},{"key":"10.1016\/j.trre.2021.100626_bb0445","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00251-008-0293-3","article-title":"Fibroproliferation in LPS-induced airway remodeling and bleomycin-induced fibrosis share common patterns of gene expression","volume":"60","author":"Brass","year":"2008","journal-title":"Immunogenetics"},{"key":"10.1016\/j.trre.2021.100626_bb0450","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0168-8278(02)00435-X","article-title":"High serum osteoprotegerin and low RANKL in primary biliary cirrhosis","volume":"38","author":"Szalay","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.trre.2021.100626_bb0455","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3109\/00365513.2010.524933","article-title":"Serum levels of osteoprotegerin in the spectrum of nonalcoholic fatty liver disease","volume":"70","author":"Yilmaz","year":"2010","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.trre.2021.100626_bb0460","doi-asserted-by":"crossref","first-page":"14550","DOI":"10.1038\/s41598-018-32738-y","article-title":"Osteoprotegerin and myocardial fibrosis in patients with aortic stenosis","volume":"8","author":"Loudon","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.trre.2021.100626_bb0465","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s40620-014-0092-x","article-title":"Osteoprotegerin and kidney disease","volume":"27","author":"Monta\u00f1ez-Barrag\u00e1n","year":"2014","journal-title":"J Nephrol"},{"key":"10.1016\/j.trre.2021.100626_bb0470","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12050471","article-title":"Osteoprotegerin is more than a possible serum marker in liver fibrosis: a study into its function in human and murine liver","volume":"12","author":"Adhyatmika","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.trre.2021.100626_bb0475","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cca.2012.09.020","article-title":"Including osteoprotegerin and collagen IV in a score-based blood test for liver fibrosis increases diagnostic accuracy","volume":"415","author":"Bosselut","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.trre.2021.100626_bb0480","series-title":"Partha Hota 1 Chandra Dass Maruti Kumaran Scott Simpson","first-page":"13","author":"Dass","year":"2018"},{"key":"10.1016\/j.trre.2021.100626_bb0485","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/thoraxjnl-2011-200863","article-title":"Deficiency of tumour necrosis factor-related apoptosis-inducing ligand exacerbates lung injury and fibrosis","volume":"67","author":"McGrath","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.trre.2021.100626_bb0490","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1165\/rcmb.2002-0140OC","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand enhances collagen production by human lung fibroblasts","volume":"28","author":"Yurovsky","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.trre.2021.100626_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013360","article-title":"Fibulin-1 is increased in asthma--a novel mediator of airway remodeling?","volume":"5","author":"Lau","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.trre.2021.100626_bb0500","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/43.4.7534784","article-title":"The association of human fibulin-1 with elastic fibers: an immunohistological, ultrastructural, and RNA study","volume":"43","author":"Roark","year":"1995","journal-title":"J Histochem Cytochem Off J Histochem Soc"},{"key":"10.1016\/j.trre.2021.100626_bb0505","doi-asserted-by":"crossref","first-page":"22600","DOI":"10.1074\/jbc.272.36.22600","article-title":"The self-association and fibronectin-binding sites of fibulin-1 map to calcium-binding epidermal growth factor-like domains","volume":"272","author":"Tran","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trre.2021.100626_bb0510","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrm1130","article-title":"Fibulins: a versatile family of extracellular matrix proteins","volume":"4","author":"Timpl","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.trre.2021.100626_bb0515","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1038\/sj.onc.1201385","article-title":"Suppression of anchorage-independent growth and matrigel invasion and delayed tumor formation by elevated expression of fibulin-1D in human fibrosarcoma-derived cell lines","volume":"15","author":"Qing","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.trre.2021.100626_bb0520","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.onc.1205171","article-title":"Estrogen induction and overexpression of fibulin-1C mRNA in ovarian cancer cells","volume":"21","author":"Moll","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.trre.2021.100626_bb0525","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1084\/jem.20070956","article-title":"Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma","volume":"204","author":"Trian","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.trre.2021.100626_bb0530","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1164\/ajrccm.164.3.2010109","article-title":"Airway smooth muscle cell proliferation is increased in asthma","volume":"164","author":"Johnson","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trre.2021.100626_bb0535","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2164-5-21","article-title":"Functional classes of bronchial mucosa genes that are differentially expressed in asthma","volume":"5","author":"Laprise","year":"2004","journal-title":"BMC Genomics"},{"key":"10.1016\/j.trre.2021.100626_bb0540","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/path.4979","article-title":"Airway remodelling and inflammation in asthma are dependent on the extracellular matrix protein fibulin-1c","volume":"243","author":"Liu","year":"2017","journal-title":"J Pathol"},{"key":"10.1016\/j.trre.2021.100626_bb0545","article-title":"Fibulin-1c regulates transforming growth factor-\u03b2 activation in pulmonary tissue fibrosis","volume":"5","author":"Liu","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.trre.2021.100626_bb0550","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/liv.12700","article-title":"Plasma pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C","volume":"35","author":"Nielsen","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.trre.2021.100626_bb0555","doi-asserted-by":"crossref","first-page":"14857","DOI":"10.1038\/s41598-019-51394-4","article-title":"Serum markers of type III and IV procollagen processing predict recurrence of fibrosis in liver transplanted patients","volume":"9","author":"Nielsen","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.trre.2021.100626_bb0560","first-page":"303","article-title":"The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters","volume":"5","author":"Nielsen","year":"2013","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.trre.2021.100626_bb0565","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.addr.2003.08.002","article-title":"Collagens--structure, function, and biosynthesis","volume":"55","author":"Gelse","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.trre.2021.100626_bb0570","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1164\/ajrccm.164.8.2011046","article-title":"Collagens I and III in a porcine bronchial model of obliterative bronchiolitis","volume":"164","author":"Alho","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trre.2021.100626_bb0575","first-page":"371","article-title":"Investigation of two novel biochemical markers of inflammation, matrix metalloproteinase and cathepsin generated fragments of C-reactive protein, in patients with ankylosing spondylitis","volume":"30","author":"Skj\u00f8t-Arkil","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.trre.2021.100626_bb0580","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.joca.2013.10.020","article-title":"Identification and characterisation of osteoarthritis patients with inflammation derived tissue turnover","volume":"22","author":"Siebuhr","year":"2014","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.trre.2021.100626_bb0585","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S2213-2600(15)00048-X","article-title":"Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study","volume":"3","author":"Jenkins","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.trre.2021.100626_bb0590","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1600-6143.2012.04079.x","article-title":"Antibodies to K-\u03b1 1 tubulin and collagen V are associated with chronic rejection after lung transplantation","volume":"12","author":"Hachem","year":"2012","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"key":"10.1016\/j.trre.2021.100626_bb0595","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.4049\/jimmunol.180.7.4487","article-title":"De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection","volume":"180","author":"Goers","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2021.100626_bb0600","first-page":"L1129","article-title":"Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection","volume":"286","author":"Sumpter","year":"2004","journal-title":"Am J Phys Lung Cell Mol Phys"},{"key":"10.1016\/j.trre.2021.100626_bb0605","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.healun.2011.01.708","article-title":"Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts","volume":"30","author":"Saini","year":"2011","journal-title":"J Hear Lung Transplant Off Publ Int Soc Hear Transplant"},{"key":"10.1016\/j.trre.2021.100626_bb0610","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.trim.2019.02.006","article-title":"Prevalence of antibodies to lung self-antigens (K\u03b11 tubulin and collagen V) and donor specific antibodies to HLA in lung transplant recipients and implications for lung transplant outcomes: single center experience","volume":"54","author":"Rao","year":"2019","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.trre.2021.100626_bb0615","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.ajpath.2011.01.058","article-title":"Resident tissue-specific mesenchymal progenitor cells contribute to fibrogenesis in human lung allografts","volume":"178","author":"Walker","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trre.2021.100626_bb0620","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1164\/rccm.200905-0674OC","article-title":"Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis","volume":"182","author":"Maher","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trre.2021.100626_bb0625","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejpb.2012.11.023","article-title":"Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2","volume":"84","author":"Ivanova","year":"2013","journal-title":"Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Fur Pharm Verfahrenstechnik eV"},{"key":"10.1016\/j.trre.2021.100626_bb0630","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.nano.2017.04.005","article-title":"Combinatorial treatment of idiopathic pulmonary fibrosis using nanoparticles with prostaglandin E and siRNA(s)","volume":"13","author":"Garbuzenko","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.trre.2021.100626_bb0635","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1172\/JCI29713","article-title":"Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts","volume":"117","author":"Lama","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trre.2021.100626_bb0640","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1164\/rccm.201005-0742OC","article-title":"Mesenchymal stromal cells in bronchoalveolar lavage as predictors of bronchiolitis obliterans syndrome","volume":"183","author":"Badri","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trre.2021.100626_bb0645","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.201105-0834OC","article-title":"Prostaglandin E 2 as an inhibitory modulator of fibrogenesis in human lung allografts","volume":"185","author":"Walker","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trre.2021.100626_bb0650","first-page":"L810","article-title":"Prostaglandin E(2) inhibits profibrotic function of human pulmonary fibroblasts by disrupting Ca(2+) signaling","volume":"316","author":"Mukherjee","year":"2019","journal-title":"Am J Phys Lung Cell Mol Phys"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X2100032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X2100032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T16:06:45Z","timestamp":1760630805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X2100032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":130,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0955470X2100032X"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2021.100626","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential of biomarkers of fibrosis in chronic lung allograft dysfunction","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2021.100626","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100626"}}